Jacqueline D. Barrientos, MD, MS, CLL Research and Treatment Program at Northwell Health Systems, advises community oncologists on how to treat patients with mantle cell lymphoma. She emphasizes the importance of seeking a second opinion for patients that are not responding to treatment.
Jacqueline D. Barrientos, MD, MS, CLL Research and Treatment Program at Northwell Health Systems, advises community oncologists on how to treat patients with mantle cell lymphoma (MCL). She emphasizes the importance of seeking a second opinion for patients that are not responding to treatment.
Other centers may have access to clinical trials that are not available to the community yet and can ultimately help the patient live longer. Barrientos says that if you are running out of options, communicate with an expert in MCL, or also look to the Leukemia & Lymphoma Society for guidance and information regarding ongoing trials for promising agents.
Unfortunately, relapse is still an issue in patients with MCL. However, new agents are showing more promise in the field. According to a paper published inTheNew England Journal of Medicineby Constantine S. Tam, MB, BS, MD, the combination of ibrutinib (Imbruvica) and venetoclax (Venclexta) had very good responses in patients with MCL, as well as many complete responses.
Cretostimogene Grenadenorepvec Shows High CR Rate in BCG-Unresponsive NMIBC
July 17th 2024Mark D. Tyson, II, MD, MPH, discussed treatment with cretostimogene grenadenorepvec in high-risk Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer with carcinoma in situ and data from the BOND-003 trial.
Read More
Phase 3 VERIFY Trial Investigates Rusfertide’s Potential in Polycythemia Vera
July 16th 2024In an interview, Aniket Bankar, MD, discussed the background, design, and goals of the phase 3 VERIFY trial of the hepcidin mimetic rusfertide for the treatment of patients with polycythemia vera.
Read More
Examining Breast Cancer Recurrence Detection Methods in a Community Oncology Setting
July 12th 2024In an interview with Targeted Oncology, Ali Duffens, MD, discussed findings from a study which investigated detecting breast cancer recurrence among women treated at Kaiser Permanente Northern California.
Read More